204 related articles for article (PubMed ID: 18754842)
1. Impact of adherence to statins on chronic heart failure in primary prevention.
Perreault S; Dragomir A; Blais L; Bérard A; Lalonde L; White M
Br J Clin Pharmacol; 2008 Nov; 66(5):706-16. PubMed ID: 18754842
[TBL] [Abstract][Full Text] [Related]
2. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
3. Persistence and adherence to cholesterol lowering agents: evidence from Régie de l'Assurance Maladie du Québec data.
Lachaine J; Rinfret S; Merikle EP; Tarride JE
Am Heart J; 2006 Jul; 152(1):164-9. PubMed ID: 16824851
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
[TBL] [Abstract][Full Text] [Related]
5. Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care.
Harley CR; Gandhi SK; Heien H; McDonough K; Nelson SP
Expert Opin Pharmacother; 2008 Apr; 9(5):669-76. PubMed ID: 18345946
[TBL] [Abstract][Full Text] [Related]
6. Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases.
Dormuth CR; Hemmelgarn BR; Paterson JM; James MT; Teare GF; Raymond CB; Lafrance JP; Levy A; Garg AX; Ernst P;
BMJ; 2013 Mar; 346():f880. PubMed ID: 23511950
[TBL] [Abstract][Full Text] [Related]
7. Impact of better adherence to statin agents in the primary prevention of coronary artery disease.
Perreault S; Dragomir A; Blais L; Bérard A; Lalonde L; White M; Pilon D
Eur J Clin Pharmacol; 2009 Oct; 65(10):1013-24. PubMed ID: 19529927
[TBL] [Abstract][Full Text] [Related]
8. Better adherence to antihypertensive agents and risk reduction of chronic heart failure.
Perreault S; Dragomir A; White M; Lalonde L; Blais L; Bérard A
J Intern Med; 2009 Aug; 266(2):207 - 18. PubMed ID: 19623691
[TBL] [Abstract][Full Text] [Related]
9. Achievement of LDL-cholesterol goal with statins after an st segment elevation myocardial infarction.
Tungsubutra W; Phongtuntakul B
J Med Assoc Thai; 2015 Feb; 98(2):129-36. PubMed ID: 25842792
[TBL] [Abstract][Full Text] [Related]
10. Lipophilicity and cardiovascular outcome in patients with CHF.
Ford JS; Tayek JA
Am Heart J; 2008 Aug; 156(2):e7; author reply e9. PubMed ID: 18657645
[No Abstract] [Full Text] [Related]
11. Considerations in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation.
Davidson M
Prev Cardiol; 2005; 8(4):244-9. PubMed ID: 16230879
[TBL] [Abstract][Full Text] [Related]
12. Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease.
Perreault S; Blais L; Dragomir A; Bouchard MH; Lalonde L; Laurier C; Collin J
Eur J Clin Pharmacol; 2005 Oct; 61(9):667-74. PubMed ID: 16151763
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of statins in the prevention of coronary heart disease events in middle-aged Finnish men.
Peura P; Martikainen J; Soini E; Hallinen T; Niskanen L
Curr Med Res Opin; 2008 Jun; 24(6):1823-32. PubMed ID: 18485270
[TBL] [Abstract][Full Text] [Related]
14. Impact of adherence to statins on coronary artery disease in primary prevention.
Bouchard MH; Dragomir A; Blais L; Bérard A; Pilon D; Perreault S
Br J Clin Pharmacol; 2007 Jun; 63(6):698-708. PubMed ID: 17214831
[TBL] [Abstract][Full Text] [Related]
15. Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study.
Schuster H; Barter PJ; Stender S; Cheung RC; Bonnet J; Morrell JM; Watkins C; Kallend D; Raza A;
Am Heart J; 2004 Apr; 147(4):705-13. PubMed ID: 15077101
[TBL] [Abstract][Full Text] [Related]
16. Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin.
Rader DJ; Davidson MH; Caplan RJ; Pears JS
Am J Cardiol; 2003 Mar; 91(5A):20C-23C; discussion 23C-24C. PubMed ID: 12646340
[TBL] [Abstract][Full Text] [Related]
17. Class effects of statins in elderly patients with congestive heart failure: a population-based analysis.
Rinfret S; Behlouli H; Eisenberg MJ; Humphries K; Tu JV; Pilote L
Am Heart J; 2008 Feb; 155(2):316-23. PubMed ID: 18215603
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice.
Ohsfeldt RL; Gandhi SK; Fox KM; Stacy TA; McKenney JM
Am J Manag Care; 2006 Nov; 12(15 Suppl):S412-23. PubMed ID: 17112329
[TBL] [Abstract][Full Text] [Related]
19. Risk of diabetes in patients treated with HMG-CoA reductase inhibitors.
Cho Y; Choe E; Lee YH; Seo JW; Choi Y; Yun Y; Wang HJ; Ahn CW; Cha BS; Lee HC; Kang ES
Metabolism; 2015 Apr; 64(4):482-8. PubMed ID: 25312577
[TBL] [Abstract][Full Text] [Related]
20. Moving branded statins to lowest copay tier improves patient adherence.
Chen SY; Shah SN; Lee YC; Boulanger L; Mardekian J; Kuznik A
J Manag Care Pharm; 2014 Jan; 20(1):34-42. PubMed ID: 24372458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]